Diversify Advisory Services LLC Invests $7.83 Million in HealthEquity, Inc. (NASDAQ:HQY)

Diversify Advisory Services LLC purchased a new stake in HealthEquity, Inc. (NASDAQ:HQY) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 95,893 shares of the company’s stock, valued at approximately $7,828,000. Diversify Advisory Services LLC owned 0.11% of HealthEquity at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in HQY. Lindbrook Capital LLC grew its holdings in HealthEquity by 22.7% in the 1st quarter. Lindbrook Capital LLC now owns 698 shares of the company’s stock valued at $57,000 after buying an additional 129 shares in the last quarter. Xponance Inc. raised its position in shares of HealthEquity by 1.2% during the fourth quarter. Xponance Inc. now owns 12,269 shares of the company’s stock worth $813,000 after acquiring an additional 147 shares during the last quarter. KLR Investment Advisors LLC raised its position in shares of HealthEquity by 4.2% during the fourth quarter. KLR Investment Advisors LLC now owns 5,914 shares of the company’s stock worth $392,000 after acquiring an additional 241 shares during the last quarter. Capstone Investment Advisors LLC grew its stake in HealthEquity by 7.0% during the fourth quarter. Capstone Investment Advisors LLC now owns 3,710 shares of the company’s stock worth $246,000 after purchasing an additional 243 shares during the period. Finally, Campbell & CO Investment Adviser LLC grew its stake in HealthEquity by 3.2% during the fourth quarter. Campbell & CO Investment Adviser LLC now owns 8,195 shares of the company’s stock worth $543,000 after purchasing an additional 254 shares during the period. Institutional investors own 99.55% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have commented on HQY. Robert W. Baird raised their price objective on HealthEquity from $98.00 to $104.00 and gave the company an “outperform” rating in a research note on Tuesday, June 4th. KeyCorp lifted their price target on HealthEquity from $95.00 to $100.00 and gave the stock an “overweight” rating in a report on Wednesday, June 5th. Raymond James boosted their target price on HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research note on Friday, June 7th. Wells Fargo & Company boosted their target price on HealthEquity from $107.00 to $110.00 and gave the company an “overweight” rating in a research note on Thursday, June 20th. Finally, JMP Securities lifted their price target on HealthEquity from $101.00 to $105.00 and gave the company a “market outperform” rating in a research report on Tuesday, June 4th. One investment analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $101.67.

Insider Transactions at HealthEquity

In other news, CEO Jon Kessler sold 32,326 shares of the stock in a transaction that occurred on Monday, June 24th. The stock was sold at an average price of $82.83, for a total value of $2,677,562.58. Following the completion of the transaction, the chief executive officer now owns 232,176 shares of the company’s stock, valued at approximately $19,231,138.08. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other HealthEquity news, Vice Chairman Stephen Neeleman sold 2,080 shares of the stock in a transaction on Friday, June 7th. The stock was sold at an average price of $85.01, for a total transaction of $176,820.80. Following the sale, the insider now directly owns 90,515 shares in the company, valued at approximately $7,694,680.15. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Jon Kessler sold 32,326 shares of the stock in a transaction on Monday, June 24th. The shares were sold at an average price of $82.83, for a total value of $2,677,562.58. Following the sale, the chief executive officer now owns 232,176 shares in the company, valued at $19,231,138.08. The disclosure for this sale can be found here. In the last quarter, insiders sold 34,806 shares of company stock valued at $2,888,383. Corporate insiders own 2.20% of the company’s stock.

HealthEquity Trading Down 1.2 %

Shares of NASDAQ HQY traded down $0.99 during midday trading on Friday, reaching $82.57. The company had a trading volume of 471,186 shares, compared to its average volume of 604,248. HealthEquity, Inc. has a one year low of $61.32 and a one year high of $88.26. The company has a quick ratio of 4.39, a current ratio of 4.39 and a debt-to-equity ratio of 0.44. The firm’s fifty day moving average price is $81.48 and its 200-day moving average price is $78.69. The stock has a market cap of $7.18 billion, a PE ratio of 89.75, a price-to-earnings-growth ratio of 1.41 and a beta of 0.57.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Monday, June 3rd. The company reported $0.55 EPS for the quarter, beating analysts’ consensus estimates of $0.47 by $0.08. The business had revenue of $287.60 million during the quarter, compared to analyst estimates of $278.78 million. HealthEquity had a return on equity of 7.77% and a net margin of 7.71%. On average, equities research analysts anticipate that HealthEquity, Inc. will post 2.12 earnings per share for the current year.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.